Deep learning models can help assess lung cancer diagnoses.

Published Date: 02 Mar 2023

A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.

Read Full News

Latest News

Skip the TB Test? IPC/NPF Say Yes for Newer Biologics in Psoriasis

Opioid Prescribing by Pain Specialists on the Rise

Opioid prescribing by pain medicine specialists increased between 2010 and 2024, but overall prescribing declined, especially for long-term use, a new study shows.

Kitchen Sponges: Can They Look Clean but Harbor Pathogens?

Kitchen sponges rapidly harbor foodborne pathogens despite appearing clean, supporting regular replacement, and improving household food hygiene.

Do Docs Need a New Approach to Combat Weight Stigma?

Fat shaming is now slim shaming, and patients with obesity on GLP-1s are taking the heat.

FDA Okays At-Home Starting Dose for Lecanemab

An FDA approval marks the first time patients or caregivers can start lecanemab treatment at home.

Blood Test Helps PCPs Dx AD With Specialist-Level Accuracy

Blood test results help primary care physicians diagnose Alzheimer’s disease with near-specialist accuracy while influencing referrals, additional testing, and treatment decisions.

Todays Updates

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability

People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Todays Updates

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability

People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Latest News

Opioid prescribing by pain medicine specialists increased between 2010 and 2024, but overall prescribing declined, especially for long-term use, a new study shows.

Kitchen sponges rapidly harbor foodborne pathogens despite appearing clean, supporting regular replacement, and improving household food hygiene.

Fat shaming is now slim shaming, and patients with obesity on GLP-1s are taking the heat.

An FDA approval marks the first time patients or caregivers can start lecanemab treatment at home.

Blood test results help primary care physicians diagnose Alzheimer’s disease with near-specialist accuracy while influencing referrals, additional testing, and treatment decisions.

News All Time

Most Child Flu Deaths Occur in Those Unvaccinated

Children and adolescents who die from influenza-related illness are less likely to have received the vaccine for the current season, per an analysis of pediatric deaths over eight seasons in the US.

Game Changers: How Lorlatinib Shifts the Landscape

Dr Mark Kris breaks down why lorlatinib is a true game changer in ALK+ NSCLC, offering unprecedented 5-year PFS data alongside essential strategies to manage its unique toxicities.

FDA Psychiatry Roundup: June 2026

A monthly overview of FDA actions for psychiatric treatments and therapies.

Adjunctive Trauma Therapy May Help Improve Psychosis Care

Trauma-focused therapy is associated with reduced PTSD symptom severity and increased remission in patients with co-occurring psychosis, a new randomized trial shows.

CADe Succeeds in Real-World Colonoscopy QI Study

AI-based computer-aided detection devices during colonoscopy was associated with higher adenoma detection rates than usual care, a pragmatic, quality improvement trial shows.

APOL1 Status May Refine Long-Term Kidney Donor Risk

High-risk APOL1 genotypes are associated with greater long-term kidney dysfunction among Black living donors, suggesting a potential role for genetic screening during donor evaluation.

Meningioma Risk Warning With Progestogen Contraceptives

The EMA has alerted healthcare professionals to a small increased risk for meningioma with the progestogen-based contraceptives desogestrel and etonogestrel.

Urologist Wins $6.8 Million in Damages in Retaliation Case

A Missouri urologist sued her employer, claiming the health system fired her after she complained about discrimination and harassment.

Majority of Moms, Newborns Get RSV Protection

Most pregnant women receive the maternal vaccine against respiratory syncytial virus, and most newborns leave the hospital protected, but gaps persist.

Tracking IBD Activity: Ultrasound May Reduce Endoscopy Use

After implementation of an intestinal ultrasound service, endoscopies performed to assess inflammatory bowel disease activity decreased by more than half.

Mild Sleep Loss Linked to Weight Gain

Six weeks of sleep restriction increased weight, waist circumference, leptin levels, and time spent inactive in adults with cardiometabolic risk.

Universal Bulk Billing Requires More Than Good Intentions

General practitioners support affordable access to care, but universal bulk billing can only succeed if it is backed by sustainable funding.

Rethinking Routine Screening of Asymptomatic Patients

A normal result feels like good medicine. For patients and physicians alike, it provides peace of mind. But when the evidence doesn't support the test, that reassurance comes at a price.

Childhood Abuse Tied to Higher Migraine Risk in Men

Childhood abuse is linked to an increased risk for past-year and lifetime migraine in men but not in women, with depression partially mediating the link, a study suggests.

Medical Trainees May Help Up Advance Care Planning

A brief trainee-led educational session may boost completion of Durable Power of Attorney for Healthcare forms and billing for advance care planning-related codes in older adults in primary care.

One Conversation Makes Testing Less Stressful for Patients

While ordering medical tests is routine, a lack of communication often leaves anxious patients decoding portal results alone. These communication strategies can help.

Recommended News For You

Mezigdomide Combinations Show Promise in Multiple Myeloma

Study finds primary-care doctors often overlook prostate cancer risk in Black men

New research points out a promising strategy for treating metastatic medulloblastoma

Community Oncology Well Suited for Advanced Cancer Patients

AI tool automates liver tumor detection and monitoring

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

The Growing Role of AI in Cancer Treatment

Recommended Articles For You

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization 

Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology 

Clinical Methods in Hematology and Quality Improvement 

Unveiling the Complexity of Multiple Myeloma Staging 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

A new drug delivery system may help patients with a rare eye cancer

3.

Kate Middleton Gives Cancer Update

4.

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

5.

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

1.

What Is A High MCV Level? Causes, Symptoms, And Treatment Options

2.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

3.

Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies

4.

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment

5.

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot